Kristy Carter (she/her)
Louise Edwards (she/her) 
This individualised approach to tapering off psychiatric medicines can help patients withdraw for good, said Dr Mark Horowitz at PSA24.
From the ECP party to the morning walks and member breakfast, pharmacists have had a vast array of social events to choose from at PSA24.
Professor Lisa Nissen revealed where she would like to see pharmacists scope of practice venture, among other experts on a panel at PSA24.
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
A bumper field of 23 Australian pharmacists have been approved by the PSA National Board for elevation to fellow status.
Launched today at PSA24, the Pharmacists in 2030 report lays out how pharmacists can achieve their full potential.
With a new host and massive new venue, this year’s conference promises to be the biggest and best one yet.
Data shows orally ingested phenylephrine is ineffective, so why does it continue to be purchased over pseudoephedrine?
LAIB is a life-changing opioid dependance treatment for some, but there are some considerations pharmacists should take into account.
A third of patients living with chronic pain have not had their medicine reviewed. An expert explains what pharmacists can do to change this.
